Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1977 1
1986 1
2001 1
2002 2
2003 6
2004 1
2005 2
2006 1
2007 3
2008 11
2009 3
2010 5
2011 1
2012 3
2013 2
2014 1
2016 5
2017 3
2018 3
2019 4
2020 4
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Substance abuse disorders.
Reid AG, Lingford-Hughes AR, Cancela LM, Kalivas PW. Reid AG, et al. Handb Clin Neurol. 2012;106:419-31. doi: 10.1016/B978-0-444-52002-9.00024-3. Handb Clin Neurol. 2012. PMID: 22608635 Review. No abstract available.
Molecular Monitoring of Chronic Myeloid Leukemia.
Dominy K, Mokretar K, Reid AG, Khorashad JS. Dominy K, et al. Among authors: reid ag. Methods Mol Biol. 2020;2065:153-173. doi: 10.1007/978-1-4939-9833-3_12. Methods Mol Biol. 2020. PMID: 31578694
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.
Claudiani S, Mason CC, Milojkovic D, Bianchi A, Pellegrini C, Di Marco A, Fiol CR, Robinson M, Ponnusamy K, Mokretar K, Chowdhury A, Albert M, Reid AG, Deininger MW, Naresh K, Apperley JF, Khorashad JS. Claudiani S, et al. Among authors: reid ag. Cancers (Basel). 2021 Sep 28;13(19):4863. doi: 10.3390/cancers13194863. Cancers (Basel). 2021. PMID: 34638347 Free PMC article.
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
Bencomo-Alvarez AE, Rubio AJ, Olivas IM, Gonzalez MA, Ellwood R, Fiol CR, Eide CA, Lara JJ, Barreto-Vargas C, Jave-Suarez LF, Nteliopoulos G, Reid AG, Milojkovic D, Druker BJ, Apperley J, Khorashad JS, Eiring AM. Bencomo-Alvarez AE, et al. Among authors: reid ag. Oncogene. 2021 Apr;40(15):2697-2710. doi: 10.1038/s41388-021-01732-6. Epub 2021 Mar 12. Oncogene. 2021. PMID: 33712704 Free PMC article.
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions.
Silvestri G, Trotta R, Stramucci L, Ellis JJ, Harb JG, Neviani P, Wang S, Eisfeld AK, Walker CJ, Zhang B, Srutova K, Gambacorti-Passerini C, Pineda G, Jamieson CHM, Stagno F, Vigneri P, Nteliopoulos G, May PC, Reid AG, Garzon R, Roy DC, Moutuou MM, Guimond M, Hokland P, Deininger MW, Fitzgerald G, Harman C, Dazzi F, Milojkovic D, Apperley JF, Marcucci G, Qi J, Polakova KM, Zou Y, Fan X, Baer MR, Calabretta B, Perrotti D. Silvestri G, et al. Among authors: reid ag. Blood Cancer Discov. 2020 Jul;1(1):48-67. doi: 10.1158/0008-5472.BCD-19-0039. Blood Cancer Discov. 2020. PMID: 32974613 Free PMC article.
59 results